364 related articles for article (PubMed ID: 27072348)
1. Ultrasound-detected joint inflammation and B cell count: related variables for rituximab-treated RA patients?
Valor L; Martínez-Estupiñán L; Janta I; Nieto JC; Ovalles-Bonilla JG; González-Fernández C; Del Rio T; Hernández-Flórez D; Monteagudo I; López-Longo FJ; Naredo E
Rheumatol Int; 2016 Jun; 36(6):793-7. PubMed ID: 27072348
[TBL] [Abstract][Full Text] [Related]
2. Relation of Doppler ultrasound synovitis versus clinical synovitis with changes in native complement component levels in rheumatoid arthritis patients treated with biologic disease-modifying anti-rheumatic drugs.
Montoro Alvarez M; Chong OY; Janta I; González C; López-Longo J; Monteagudo I; Valor L; Garrido J; Lau IS; Rosman A; Naredo E; Carreño L
Clin Exp Rheumatol; 2015; 33(2):141-5. PubMed ID: 25665178
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound-detected activity in rheumatoid arthritis on methotrexate therapy: Which joints and tendons should be assessed to predict unstable remission?
Janta I; Valor L; De la Torre I; Martínez-Estupiñán L; Nieto JC; Ovalles-Bonilla JG; Martínez-Barrio J; Bello N; Hinojosa M; Montoro M; González CM; López-Longo J; Monteagudo I; Carreño L; Naredo E
Rheumatol Int; 2016 Mar; 36(3):387-96. PubMed ID: 26712373
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal power Doppler ultrasonographic assessment of joint inflammatory activity in early rheumatoid arthritis: predictive value in disease activity and radiologic progression.
Naredo E; Collado P; Cruz A; Palop MJ; Cabero F; Richi P; Carmona L; Crespo M
Arthritis Rheum; 2007 Feb; 57(1):116-24. PubMed ID: 17266071
[TBL] [Abstract][Full Text] [Related]
5. Ultrasound detection of subclinical synovitis in rheumatoid arthritis patients in clinical remission: a new reduced-joint assessment in 3 target joints.
Picchianti Diamanti A; Navarini L; Messina F; Markovic M; Arcarese L; Basta F; Meneguzzi G; Margiotta DPE; Laganà B; Afeltra A; D'Amelio R; Iagnocco A
Clin Exp Rheumatol; 2018; 36(6):984-989. PubMed ID: 29998842
[TBL] [Abstract][Full Text] [Related]
6. Does ultrasound-scored synovitis depend on the pharmacokinetics of subcutaneous anti-TNF agents in patients with rheumatoid arthritis?
Naredo E; Hinojosa M; Valor L; Hernández-Flórez D; Mata-Martínez C; Serrano-Benavente B; Del Río T; Bello N; Montoro M; Nieto-González JC; González CM; López-Longo FJ; Monteagudo I; Carreño L
Rheumatology (Oxford); 2014 Nov; 53(11):2088-94. PubMed ID: 24939676
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of power Doppler ultrasound for prediction of re-therapy with rituximab in rheumatoid arthritis: a prospective study of longstanding rheumatoid arthritis patients.
Reiche BE; Ohrndorf S; Feist E; Messerschmidt J; Burmester GR; Backhaus M
Arthritis Care Res (Hoboken); 2014 Feb; 66(2):204-16. PubMed ID: 23925935
[TBL] [Abstract][Full Text] [Related]
8. Tightening up? Impact of musculoskeletal ultrasound disease activity assessment on early rheumatoid arthritis patients treated using a treat to target strategy.
Dale J; Purves D; McConnachie A; McInnes I; Porter D
Arthritis Care Res (Hoboken); 2014 Jan; 66(1):19-26. PubMed ID: 24376248
[TBL] [Abstract][Full Text] [Related]
9. High-resolution ultrasound confirms reduced synovial hyperplasia following rituximab treatment in rheumatoid arthritis.
Ziswiler HR; Aeberli D; Villiger PM; Möller B
Rheumatology (Oxford); 2009 Aug; 48(8):939-43. PubMed ID: 19491302
[TBL] [Abstract][Full Text] [Related]
10. Serum calprotectin (S100A8/9): an independent predictor of ultrasound synovitis in patients with rheumatoid arthritis.
Hurnakova J; Zavada J; Hanova P; Hulejova H; Klein M; Mann H; Sleglova O; Olejarova M; Forejtova S; Ruzickova O; Komarc M; Vencovsky J; Pavelka K; Senolt L
Arthritis Res Ther; 2015 Sep; 17(1):252. PubMed ID: 26373925
[TBL] [Abstract][Full Text] [Related]
11. Ultrasound resistive index, power Doppler, and clinical parameters in established rheumatoid arthritis.
Bisi MC; do Prado AD; Piovesan DM; Bredemeier M; da Silveira IG; de Mendonça JA; Staub HL
Clin Rheumatol; 2017 Apr; 36(4):947-951. PubMed ID: 27995383
[TBL] [Abstract][Full Text] [Related]
12. From A Formal Training Program In Musculoskeletal Ultrasound (MSUS) To A High Reproducibility for MSUS Ultrasound In Rheumatoid Arthritis.
Villota O; Diaz M; Ceron C; Moller I; Naredo E; Saaibi DL
Curr Rheumatol Rev; 2018; 14(3):264-270. PubMed ID: 28758585
[TBL] [Abstract][Full Text] [Related]
13. Using a DAS28-CRP-steered treat-to-target strategy does not eliminate subclinical inflammation as assessed by ultrasonography in rheumatoid arthritis patients in longstanding clinical remission.
Terslev L; Brahe CH; Østergaard M; Fana V; Ammitzbøll-Danielsen M; Møller T; Krabbe S; Hetland ML; Døhn UM
Arthritis Res Ther; 2021 Feb; 23(1):48. PubMed ID: 33522948
[TBL] [Abstract][Full Text] [Related]
14. Ultrasound power Doppler synovitis is associated with plasma IL-6 in established rheumatoid arthritis.
do Prado AD; Bisi MC; Piovesan DM; Bredemeier M; Batista TS; Petersen L; Bauer ME; da Silveira IG; Mendonça JA; Staub HL
Cytokine; 2016 Jul; 83():27-32. PubMed ID: 27026419
[TBL] [Abstract][Full Text] [Related]
15. Prediction of relapse after discontinuation of biologic agents by ultrasonographic assessment in patients with rheumatoid arthritis in clinical remission: high predictive values of total gray-scale and power Doppler scores that represent residual synovial inflammation before discontinuation.
Iwamoto T; Ikeda K; Hosokawa J; Yamagata M; Tanaka S; Norimoto A; Sanayama Y; Nakagomi D; Takahashi K; Hirose K; Sugiyama T; Sueishi M; Nakajima H
Arthritis Care Res (Hoboken); 2014 Oct; 66(10):1576-81. PubMed ID: 24515410
[TBL] [Abstract][Full Text] [Related]
16. Subclinical synovitis and tenosynovitis by ultrasonography (US) 7 score in patients with rheumatoid arthritis treated with synthetic drugs, in clinical remission by DAS28.
Ventura-Ríos L; Sánchez Bringas G; Hernández-Díaz C; Cruz-Arenas E; Burgos-Vargas R
Reumatol Clin (Engl Ed); 2019; 15(5):e5-e9. PubMed ID: 29198500
[TBL] [Abstract][Full Text] [Related]
17. Power Doppler ultrasound monitoring of response to anti-tumour necrosis factor alpha treatment in patients with rheumatoid arthritis.
Iagnocco A; Finucci A; Ceccarelli F; Perricone C; Iorgoveanu V; Valesini G
Rheumatology (Oxford); 2015 Oct; 54(10):1890-6. PubMed ID: 26070937
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of ultrasonographic assessment of disease activity in response to tumor necrosis factor-α inhibitor treatment in rheumatoid arthritis: a prospective cohort study.
Inanc N; Ozen G; Direskeneli H
Clin Exp Rheumatol; 2016; 34(1):156. PubMed ID: 26575409
[No Abstract] [Full Text] [Related]
19. Three-dimensional volumetric ultrasound: a valid method for blinded assessment of response to therapy in rheumatoid arthritis.
Naredo E; Acebes C; Brito E; de Agustín JJ; de Miguel E; Mayordomo L; Möller I; Moragues C; Rejón E; Rodriguez A; Uson J; Garrido J; Martínez-Hernández D;
J Rheumatol; 2013 Mar; 40(3):253-60. PubMed ID: 23322469
[TBL] [Abstract][Full Text] [Related]
20. Improvement of large-joint ultrasonographic synovitis is delayed in patients with newly diagnosed rheumatoid arthritis: results of a 12-month clinical and ultrasonographic follow-up study of a local cohort.
Harman H; Tekeoğlu İ; Takçı S; Kamanlı A; Nas K; Harman S
Clin Rheumatol; 2015 Aug; 34(8):1367-74. PubMed ID: 25833144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
